Strategic partnerships PatientMpower has ongoing and recent collaborations with high-profile healthcare centers (Manchester NHS Trust, UZ Leuven) and a history of integrating remote monitoring into clinical pathways, presenting a clear path for multi-center expansion and enterprise partnerships.

AI expansion The company is actively developing an AI-powered tool for lung disease prediction, signaling opportunities to license or co-develop predictive analytics capabilities with hospitals, payers, and research institutions seeking advanced risk stratification.

At‑home monitoring focus With tools enabling home spirometry and oximetry connected to EMR workflows, there is strong upside selling into integrated remote patient monitoring programs and value-based care initiatives that aim to reduce in-person visits.

Global scale potential Having implementations in the US, UK, and Ireland positions PatientMpower to target international hospital systems and transplant centers seeking scalable remote monitoring platforms with interoperability to EMR systems.

Growth through automation Recent feature launches such as automated quality control for home spirometry indicate a drive toward operational efficiency and data reliability, presenting upsell opportunities for premium analytics, workflows, and managed services.